Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...
A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
By Dr. Sanchari Sinha Dutta, Ph.D. Three days of oat-heavy meals spark gut-derived phenolic metabolites linked to rapid ...